Search research articles
Contact Us
Filters
Showing results (1-10 of 109) with videos related to
Page
of 11
Sort By:
Current Pharmaceutical Design
|
January 1, 2010
Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy
Steve D Wilton, Susan Fletcher
Current Opinion in Molecular Therapeutics
|
April 14, 2006
Modification of pre-mRNA processing: application to dystrophin expression
Steve D Wilton, Susan Fletcher
Current Gene Therapy
|
October 28, 2005
RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes
Steve D Wilton, Susan Fletcher
The Application of Clinical Genetics
|
June 19, 2013
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
Steve D Wilton, Sue Fletcher
Neurology India
|
November 1, 2008
Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible?
Steve D Wilton, Susan Fletcher
Current Gene Therapy
|
April 2, 2011
RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes
Steve D Wilton, Susan Fletcher
Methods in Molecular Biology (Clifton, N.J.)
|
March 29, 2012
Optimizing splice-switching oligomer sequences using 2'-O-methyl phosphorothioate chemistry
Carl Adkin, Sue Fletcher, Steve D Wilton
Current Molecular Pharmacology
|
December 22, 2009
Personalised genetic intervention for Duchenne muscular dystrophy: antisense oligomers and exon skipping
Chalermchai Mitrpant, Sue Fletcher, Steve D Wilton
Methods in Molecular Biology (Clifton, N.J.)
|
July 28, 2025
Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment
Kane Greer, Sue Fletcher, Steve D Wilton
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2018
Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment
Kane Greer, Sue Fletcher, Steve D Wilton
Page
of 11
Search research articles
Search
Showing results (1-10 of 109) with videos related to
Sort By:
Page
of 11
Current Pharmaceutical Design
|
January 1, 2010
Splice modification to restore functional dystrophin synthesis in Duchenne muscular dystrophy
Steve D Wilton, Susan Fletcher
Current Opinion in Molecular Therapeutics
|
April 14, 2006
Modification of pre-mRNA processing: application to dystrophin expression
Steve D Wilton, Susan Fletcher
Current Gene Therapy
|
October 28, 2005
RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes
Steve D Wilton, Susan Fletcher
The Application of Clinical Genetics
|
June 19, 2013
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
Steve D Wilton, Sue Fletcher
Neurology India
|
November 1, 2008
Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible?
Steve D Wilton, Susan Fletcher
Current Gene Therapy
|
April 2, 2011
RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes
Steve D Wilton, Susan Fletcher
Methods in Molecular Biology (Clifton, N.J.)
|
March 29, 2012
Optimizing splice-switching oligomer sequences using 2'-O-methyl phosphorothioate chemistry
Carl Adkin, Sue Fletcher, Steve D Wilton
Current Molecular Pharmacology
|
December 22, 2009
Personalised genetic intervention for Duchenne muscular dystrophy: antisense oligomers and exon skipping
Chalermchai Mitrpant, Sue Fletcher, Steve D Wilton
Methods in Molecular Biology (Clifton, N.J.)
|
July 28, 2025
Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment
Kane Greer, Sue Fletcher, Steve D Wilton
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2018
Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment
Kane Greer, Sue Fletcher, Steve D Wilton
Page
of 11